Clinical Trials Directory

Trials / Unknown

UnknownNCT06355856

Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss

Phase IV, National, Unicentric, Comparative, Double-Blind, Randomized, Non- Inferiority Clinical Trial to Evaluate the Efficacy and Safety of DNN.22.17.036 Compared to 10573048700 in the Treatment of Androgenetic Alopecia

Status
Unknown
Phase
Phase 4
Study type
Interventional
Enrollment
196 (estimated)
Sponsor
Ache Laboratorios Farmaceuticos S.A. · Industry
Sex
Male
Age
25 Years – 60 Years
Healthy volunteers
Not accepted

Summary

Evaluation of the efficacy and safety of DNN.22.17.036 versus 10573048700 in the treatment of male pattern hair loss.

Conditions

Interventions

TypeNameDescription
DRUGDNN.22.17.036Apply twice daily to the affected area and around it.
DRUG10573048700Apply twice daily to the affected area and around it.

Timeline

Start date
2024-04-01
Primary completion
2025-05-01
Completion
2025-05-01
First posted
2024-04-10
Last updated
2024-04-10

Source: ClinicalTrials.gov record NCT06355856. Inclusion in this directory is not an endorsement.

Efficacy/ Safety of DNN.22.17.036 in Male Patients With Pattern Hair Loss (NCT06355856) · Clinical Trials Directory